Currently, there are 279.82M common shares owned by the public and among those 241.18M shares have been available to trade.
The company’s stock has a 5-day price change of 12.28% and 17.37% over the past three months. It has a 12-month low price of $2.61 and touched a high of $18.63 over the same period. CORZ has an average intraday trading volume of 10.60 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 5.96%, -2.56%, and 45.83% respectively.
Institutional ownership of Core Scientific Inc (NASDAQ: CORZ) shares accounts for 62.32% of the company’s 279.82M shares outstanding.
It has a market capitalization of $4.26B and a beta (3y monthly) value of 7.06. The earnings-per-share (ttm) stands at -$5.45. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.74% over the week and 5.98% over the month.
Analysts forecast that Core Scientific Inc (CORZ) will achieve an EPS of 0.03 for the current quarter, 0.17 for the next quarter and 0.91 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.03 while analysts give the company a high EPS estimate of 0.03. Comparatively, EPS for the current quarter was -0.2 a year ago. Earnings per share for the fiscal year are expected to decrease by -516.31%, and 102.99% over the next financial year.
Looking at the support for the CORZ, a number of firms have released research notes about the stock. Craig Hallum stated their Buy rating for the stock in a research note on January 21, 2025, with the firm’s price target at $24. ROTH MKM coverage for the Core Scientific Inc (CORZ) stock in a research note released on November 15, 2024 offered a Buy rating with a price target of $25.50. Jefferies was of a view on October 28, 2024 that the stock is Buy, while Macquarie gave the stock Outperform rating on September 25, 2024, issuing a price target of $16. Canaccord Genuity on their part issued Buy rating on September 23, 2024.
